Modified bloodroot compound shows promise against multidrug-resistant tuberculosis

FHS
October 8, 2024
11:50 pm

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study.

Cannabis Q2 Earnings Season Approaches

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since

July 23, 2024

OVUM highlights the potential of AI in revolutionizing IVF

The reproductive and fertility wellness brand, OVUM, highlights the potential of artificial intelligence (AI) in revolutionizing the In vitro fertilization (IVF) field.

July 1, 2023

Progress in battle against stomach cancer

Researchers at Ludwig-Maximilians-Universität München (LMU) in Germany have discovered a weakness in the bacterium Helicobacter pylori, which could be exploited to develop new drugs.H. pylori,

April 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.